1. Academic Validation
  2. Interrupting cyclic dinucleotide-cGAS-STING axis with small molecules

Interrupting cyclic dinucleotide-cGAS-STING axis with small molecules

  • Medchemcomm. 2019 Aug 15;10(12):1999-2023. doi: 10.1039/c8md00555a.
Herman O Sintim 1 2 3 Clinton G Mikek 1 Modi Wang 1 Moloud A Sooreshjani 1
Affiliations

Affiliations

  • 1 Department of Chemistry , Purdue University , 560 Oval Drive , West Lafayette , IN 47907 , USA . Email: hsintim@purdue.edu.
  • 2 Institute for Drug Discovery , Purdue University , 720 Clinic Drive , West Lafayette , IN 47907 , USA.
  • 3 Purdue Institute of Inflammation and Infectious Diseases , Purdue University , West Lafayette , IN 47907 , USA.
Abstract

The cyclic dinucleotide-cGAS-STING axis plays important roles in host immunity. Activation of this signaling pathway, via cytosolic sensing of bacterial-derived c-di-GMP/c-di-AMP or host-derived cGAMP, leads to the production of inflammatory interferons and cytokines that help resolve Infection. Small molecule activators of the cGAS-STING axis have the potential to augment immune response against various pathogens or Cancer. The aberrant activation of this pathway, due to gain-of-function mutations in any of the proteins that are part of the signaling axis, could lead to various autoimmune diseases. Inhibiting various nodes of the cGAS-STING axis could provide relief to patients with autoimmune diseases. Many excellent reviews on the cGAS-STING axis have been published recently, and these have mainly focused on the molecular details of the cGAS-STING pathway. This review however focuses on small molecules that can be used to modulate various aspects of the cGAS-STING pathway, as well as Other parallel inflammatory pathways.

Figures